世界の肺炎球菌ワクチン市場インサイト・予測（～2027年）

• 英文タイトル：Global Pneumococcal Bacteria Vaccine Market Insights and Forecast to 2027

• レポートコード：QY2108PAL4006 • 出版社/出版日：QYResearch / 2021年8月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、95ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥725,200 (USD4,900)	▷ お問い合わせ
Multi User	￥1,087,800 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,450,400 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

本調査資料は肺炎球菌ワクチンの世界市場の現状について調査・分析し、2027年までの市場を予測しました。肺炎球菌ワクチンの世界市場概要、メーカー別の競争状況と市場シェア、種類別市場規模（PPSV 23、PCV 13、PCV 10）、用途別市場規模（幼児、子供、大人）、主要地域別市場規模（北米・アメリカ、ヨーロッパ、アジア・日本・中国・インド、中南米、中東・アフリカ）、関連企業の情報、バリューチェーン・販売チャネル、市場動向などを収録しています。 ・肺炎球菌ワクチンの世界市場概要 ・メーカー別の競争状況、市場シェア ・肺炎球菌ワクチンの種類別市場規模：PPSV 23、PCV 13、PCV 10 ・肺炎球菌ワクチンの用途別市場規模：幼児、子供、大人 ・北米の肺炎球菌ワクチン市場規模2016-2027：種類別、用途別、国別（アメリカ、カナダ） ・ヨーロッパの肺炎球菌ワクチン市場規模2016-2027：種類別、用途別、国別（ドイツ、フランス、イギリス） ・アジアの肺炎球菌ワクチン市場規模2016-2027：種類別、用途別、国別（日本、中国、インド、韓国） ・中南米の肺炎球菌ワクチン市場規模2016-2027：種類別、用途別、国別（メキシコ、ブラジル） ・中東・アフリカの肺炎球菌ワクチン市場規模2016-2027：種類別、用途別、国別（トルコ、サウジアラビア） ・企業情報：Merck、Sanofi、Sinopharm、Pfizer、Walvax、GSK ・肺炎球菌ワクチンのバリューチェーン・販売チャネル分析 ・肺炎球菌ワクチンの世界市場動向

Pneumococcal Vaccine is a kind of vaccine used to prevent infection caused by pneumococcal bacteria.

Market Analysis and Insights: Global Pneumococcal Bacteria Vaccine Market
The global Pneumococcal Bacteria Vaccine market is valued at US$ XX million in 2020. The market size will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2021-2027.

Global Pneumococcal Bacteria Vaccine Scope and Segment
Pneumococcal Bacteria Vaccine market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Pneumococcal Bacteria Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2016-2027.

Segment by Type
PPSV 23
PCV 13
PCV 10

Segment by Application
Infant
Children
Adult

By Company
Merck
Sanofi
Sinopharm
Pfizer
Walvax
GSK

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

レポート目次

---

1 Study Coverage
1.1 Pneumococcal Bacteria Vaccine Product Introduction
1.2 Market by Type
1.2.1 Global Pneumococcal Bacteria Vaccine Market Size Growth Rate by Type
1.2.2 PPSV 23
1.2.3 PCV 13
1.2.4 PCV 10
1.3 Market by Application
1.3.1 Global Pneumococcal Bacteria Vaccine Market Size Growth Rate by Application
1.3.2 Infant
1.3.3 Children
1.3.4 Adult
1.4 Study Objectives
1.5 Years Considered

2 Executive Summary
2.1 Global Pneumococcal Bacteria Vaccine Sales Estimates and Forecasts 2016-2027
2.2 Global Pneumococcal Bacteria Vaccine Revenue Estimates and Forecasts 2016-2027
2.3 Global Pneumococcal Bacteria Vaccine Revenue by Region: 2016 VS 2021 VS 2027
2.4 Global Top Pneumococcal Bacteria Vaccine Regions by Sales
2.4.1 Global Top Pneumococcal Bacteria Vaccine Regions by Sales (2016-2021)
2.4.2 Global Top Pneumococcal Bacteria Vaccine Regions by Sales (2022-2027)
2.5 Global Top Pneumococcal Bacteria Vaccine Regions by Revenue
2.5.1 Global Top Pneumococcal Bacteria Vaccine Regions by Revenue (2016-2021)
2.5.2 Global Top Pneumococcal Bacteria Vaccine Regions by Revenue (2022-2027)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa

3 Competition by Manufacturers
3.1 Global Pneumococcal Bacteria Vaccine Sales by Manufacturers
3.1.1 Global Top Pneumococcal Bacteria Vaccine Manufacturers by Sales (2016-2021)
3.1.2 Global Top Pneumococcal Bacteria Vaccine Manufacturers Market Share by Sales (2016-2021)
3.1.3 Global Top 10 and Top 5 Companies by Pneumococcal Bacteria Vaccine Sales in 2020
3.2 Global Pneumococcal Bacteria Vaccine Revenue by Manufacturers
3.2.1 Global Top Pneumococcal Bacteria Vaccine Manufacturers by Revenue (2016-2021)
3.2.2 Global Top Pneumococcal Bacteria Vaccine Manufacturers Market Share by Revenue (2016-2021)
3.2.3 Global Top 10 and Top 5 Companies by Pneumococcal Bacteria Vaccine Revenue in 2020
3.3 Global Pneumococcal Bacteria Vaccine Sales Price by Manufacturers
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Pneumococcal Bacteria Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Pneumococcal Bacteria Vaccine Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Global Pneumococcal Bacteria Vaccine Sales by Type
4.1.1 Global Pneumococcal Bacteria Vaccine Historical Sales by Type (2016-2021)
4.1.2 Global Pneumococcal Bacteria Vaccine Forecasted Sales by Type (2022-2027)
4.1.3 Global Pneumococcal Bacteria Vaccine Sales Market Share by Type (2016-2027)
4.2 Global Pneumococcal Bacteria Vaccine Revenue by Type
4.2.1 Global Pneumococcal Bacteria Vaccine Historical Revenue by Type (2016-2021)
4.2.2 Global Pneumococcal Bacteria Vaccine Forecasted Revenue by Type (2022-2027)
4.2.3 Global Pneumococcal Bacteria Vaccine Revenue Market Share by Type (2016-2027)
4.3 Global Pneumococcal Bacteria Vaccine Price by Type
4.3.1 Global Pneumococcal Bacteria Vaccine Price by Type (2016-2021)
4.3.2 Global Pneumococcal Bacteria Vaccine Price Forecast by Type (2022-2027)

5 Market Size by Application
5.1 Global Pneumococcal Bacteria Vaccine Sales by Application
5.1.1 Global Pneumococcal Bacteria Vaccine Historical Sales by Application (2016-2021)
5.1.2 Global Pneumococcal Bacteria Vaccine Forecasted Sales by Application (2022-2027)
5.1.3 Global Pneumococcal Bacteria Vaccine Sales Market Share by Application (2016-2027)
5.2 Global Pneumococcal Bacteria Vaccine Revenue by Application
5.2.1 Global Pneumococcal Bacteria Vaccine Historical Revenue by Application (2016-2021)
5.2.2 Global Pneumococcal Bacteria Vaccine Forecasted Revenue by Application (2022-2027)
5.2.3 Global Pneumococcal Bacteria Vaccine Revenue Market Share by Application (2016-2027)
5.3 Global Pneumococcal Bacteria Vaccine Price by Application
5.3.1 Global Pneumococcal Bacteria Vaccine Price by Application (2016-2021)
5.3.2 Global Pneumococcal Bacteria Vaccine Price Forecast by Application (2022-2027)

6 North America
6.1 North America Pneumococcal Bacteria Vaccine Market Size by Type
6.1.1 North America Pneumococcal Bacteria Vaccine Sales by Type (2016-2027)
6.1.2 North America Pneumococcal Bacteria Vaccine Revenue by Type (2016-2027)
6.2 North America Pneumococcal Bacteria Vaccine Market Size by Application
6.2.1 North America Pneumococcal Bacteria Vaccine Sales by Application (2016-2027)
6.2.2 North America Pneumococcal Bacteria Vaccine Revenue by Application (2016-2027)
6.3 North America Pneumococcal Bacteria Vaccine Market Size by Country
6.3.1 North America Pneumococcal Bacteria Vaccine Sales by Country (2016-2027)
6.3.2 North America Pneumococcal Bacteria Vaccine Revenue by Country (2016-2027)
6.3.3 United States
6.3.4 Canada

7 Europe
7.1 Europe Pneumococcal Bacteria Vaccine Market Size by Type
7.1.1 Europe Pneumococcal Bacteria Vaccine Sales by Type (2016-2027)
7.1.2 Europe Pneumococcal Bacteria Vaccine Revenue by Type (2016-2027)
7.2 Europe Pneumococcal Bacteria Vaccine Market Size by Application
7.2.1 Europe Pneumococcal Bacteria Vaccine Sales by Application (2016-2027)
7.2.2 Europe Pneumococcal Bacteria Vaccine Revenue by Application (2016-2027)
7.3 Europe Pneumococcal Bacteria Vaccine Market Size by Country
7.3.1 Europe Pneumococcal Bacteria Vaccine Sales by Country (2016-2027)
7.3.2 Europe Pneumococcal Bacteria Vaccine Revenue by Country (2016-2027)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia

8 Asia Pacific
8.1 Asia Pacific Pneumococcal Bacteria Vaccine Market Size by Type
8.1.1 Asia Pacific Pneumococcal Bacteria Vaccine Sales by Type (2016-2027)
8.1.2 Asia Pacific Pneumococcal Bacteria Vaccine Revenue by Type (2016-2027)
8.2 Asia Pacific Pneumococcal Bacteria Vaccine Market Size by Application
8.2.1 Asia Pacific Pneumococcal Bacteria Vaccine Sales by Application (2016-2027)
8.2.2 Asia Pacific Pneumococcal Bacteria Vaccine Revenue by Application (2016-2027)
8.3 Asia Pacific Pneumococcal Bacteria Vaccine Market Size by Region
8.3.1 Asia Pacific Pneumococcal Bacteria Vaccine Sales by Region (2016-2027)
8.3.2 Asia Pacific Pneumococcal Bacteria Vaccine Revenue by Region (2016-2027)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia

9 Latin America
9.1 Latin America Pneumococcal Bacteria Vaccine Market Size by Type
9.1.1 Latin America Pneumococcal Bacteria Vaccine Sales by Type (2016-2027)
9.1.2 Latin America Pneumococcal Bacteria Vaccine Revenue by Type (2016-2027)
9.2 Latin America Pneumococcal Bacteria Vaccine Market Size by Application
9.2.1 Latin America Pneumococcal Bacteria Vaccine Sales by Application (2016-2027)
9.2.2 Latin America Pneumococcal Bacteria Vaccine Revenue by Application (2016-2027)
9.3 Latin America Pneumococcal Bacteria Vaccine Market Size by Country
9.3.1 Latin America Pneumococcal Bacteria Vaccine Sales by Country (2016-2027)
9.3.2 Latin America Pneumococcal Bacteria Vaccine Revenue by Country (2016-2027)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina

10 Middle East and Africa
10.1 Middle East and Africa Pneumococcal Bacteria Vaccine Market Size by Type
10.1.1 Middle East and Africa Pneumococcal Bacteria Vaccine Sales by Type (2016-2027)
10.1.2 Middle East and Africa Pneumococcal Bacteria Vaccine Revenue by Type (2016-2027)
10.2 Middle East and Africa Pneumococcal Bacteria Vaccine Market Size by Application
10.2.1 Middle East and Africa Pneumococcal Bacteria Vaccine Sales by Application (2016-2027)
10.2.2 Middle East and Africa Pneumococcal Bacteria Vaccine Revenue by Application (2016-2027)
10.3 Middle East and Africa Pneumococcal Bacteria Vaccine Market Size by Country
10.3.1 Middle East and Africa Pneumococcal Bacteria Vaccine Sales by Country (2016-2027)
10.3.2 Middle East and Africa Pneumococcal Bacteria Vaccine Revenue by Country (2016-2027)
10.3.3 Turkey
10.3.4 Saudi Arabia

11 Company Profiles
11.1 Merck
11.1.1 Merck Corporation Information
11.1.2 Merck Overview
11.1.3 Merck Pneumococcal Bacteria Vaccine Sales, Price, Revenue and Gross Margin (2016-2021)
11.1.4 Merck Pneumococcal Bacteria Vaccine Product Description
11.1.5 Merck Recent Developments
11.2 Sanofi
11.2.1 Sanofi Corporation Information
11.2.2 Sanofi Overview
11.2.3 Sanofi Pneumococcal Bacteria Vaccine Sales, Price, Revenue and Gross Margin (2016-2021)
11.2.4 Sanofi Pneumococcal Bacteria Vaccine Product Description
11.2.5 Sanofi Recent Developments
11.3 Sinopharm
11.3.1 Sinopharm Corporation Information
11.3.2 Sinopharm Overview
11.3.3 Sinopharm Pneumococcal Bacteria Vaccine Sales, Price, Revenue and Gross Margin (2016-2021)
11.3.4 Sinopharm Pneumococcal Bacteria Vaccine Product Description
11.3.5 Sinopharm Recent Developments
11.4 Pfizer
11.4.1 Pfizer Corporation Information
11.4.2 Pfizer Overview
11.4.3 Pfizer Pneumococcal Bacteria Vaccine Sales, Price, Revenue and Gross Margin (2016-2021)
11.4.4 Pfizer Pneumococcal Bacteria Vaccine Product Description
11.4.5 Pfizer Recent Developments
11.5 Walvax
11.5.1 Walvax Corporation Information
11.5.2 Walvax Overview
11.5.3 Walvax Pneumococcal Bacteria Vaccine Sales, Price, Revenue and Gross Margin (2016-2021)
11.5.4 Walvax Pneumococcal Bacteria Vaccine Product Description
11.5.5 Walvax Recent Developments
11.6 GSK
11.6.1 GSK Corporation Information
11.6.2 GSK Overview
11.6.3 GSK Pneumococcal Bacteria Vaccine Sales, Price, Revenue and Gross Margin (2016-2021)
11.6.4 GSK Pneumococcal Bacteria Vaccine Product Description
11.6.5 GSK Recent Developments

12 Value Chain and Sales Channels Analysis
12.1 Pneumococcal Bacteria Vaccine Value Chain Analysis
12.2 Pneumococcal Bacteria Vaccine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Pneumococcal Bacteria Vaccine Production Mode & Process
12.4 Pneumococcal Bacteria Vaccine Sales and Marketing
12.4.1 Pneumococcal Bacteria Vaccine Sales Channels
12.4.2 Pneumococcal Bacteria Vaccine Distributors
12.5 Pneumococcal Bacteria Vaccine Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Pneumococcal Bacteria Vaccine Industry Trends
13.2 Pneumococcal Bacteria Vaccine Market Drivers
13.3 Pneumococcal Bacteria Vaccine Market Challenges
13.4 Pneumococcal Bacteria Vaccine Market Restraints

14 Key Findings in The Global Pneumococcal Bacteria Vaccine Study

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Global Pneumococcal Bacteria Vaccine Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of PPSV 23
Table 3. Major Manufacturers of PCV 13
Table 4. Major Manufacturers of PCV 10
Table 5. Global Pneumococcal Bacteria Vaccine Market Size Growth Rate by Application, 2016 VS 2021 VS 2027 (US$ Million)
Table 6. Global Pneumococcal Bacteria Vaccine Revenue by Region: 2016 VS 2021 VS 2027 (US$ Million)
Table 7. Global Pneumococcal Bacteria Vaccine Sales by Region (2016-2021) & (K Units)
Table 8. Global Pneumococcal Bacteria Vaccine Sales Market Share by Region (2016-2021)
Table 9. Global Pneumococcal Bacteria Vaccine Sales by Region (2022-2027) & (K Units)
Table 10. Global Pneumococcal Bacteria Vaccine Sales Market Share by Region (2022-2027)
Table 11. Global Pneumococcal Bacteria Vaccine Revenue by Region (2016-2021) & (US$ Million)
Table 12. Global Pneumococcal Bacteria Vaccine Revenue Market Share by Region (2016-2021)
Table 13. Global Pneumococcal Bacteria Vaccine Revenue by Region (2022-2027) & (US$ Million)
Table 14. Global Pneumococcal Bacteria Vaccine Revenue Market Share by Region (2022-2027)
Table 15. Global Pneumococcal Bacteria Vaccine Sales by Manufacturers (2016-2021) & (K Units)
Table 16. Global Pneumococcal Bacteria Vaccine Sales Share by Manufacturers (2016-2021)
Table 17. Global Pneumococcal Bacteria Vaccine Revenue by Manufacturers (2016-2021) & (US$ Million)
Table 18. Global Pneumococcal Bacteria Vaccine Revenue Share by Manufacturers (2016-2021)
Table 19. Pneumococcal Bacteria Vaccine Price by Manufacturers 2016-2021 (US$/Unit)
Table 20. Global Pneumococcal Bacteria Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 21. Global Pneumococcal Bacteria Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pneumococcal Bacteria Vaccine as of 2020)
Table 22. Pneumococcal Bacteria Vaccine Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Pneumococcal Bacteria Vaccine Product Offered
Table 24. Date of Manufacturers Enter into Pneumococcal Bacteria Vaccine Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Pneumococcal Bacteria Vaccine Sales by Type (2016-2021) & (K Units)
Table 27. Global Pneumococcal Bacteria Vaccine Sales by Type (2022-2027) & (K Units)
Table 28. Global Pneumococcal Bacteria Vaccine Sales Share by Type (2016-2021)
Table 29. Global Pneumococcal Bacteria Vaccine Sales Share by Type (2022-2027)
Table 30. Global Pneumococcal Bacteria Vaccine Revenue by Type (2016-2021) & (US$ Million)
Table 31. Global Pneumococcal Bacteria Vaccine Revenue by Type (2022-2027) & (US$ Million)
Table 32. Global Pneumococcal Bacteria Vaccine Revenue Share by Type (2016-2021)
Table 33. Global Pneumococcal Bacteria Vaccine Revenue Share by Type (2022-2027)
Table 34. Pneumococcal Bacteria Vaccine Price by Type (2016-2021) & (US$/Unit)
Table 35. Global Pneumococcal Bacteria Vaccine Price Forecast by Type (2022-2027) & (US$/Unit)
Table 36. Global Pneumococcal Bacteria Vaccine Sales by Application (2016-2021) & (K Units)
Table 37. Global Pneumococcal Bacteria Vaccine Sales by Application (2022-2027) & (K Units)
Table 38. Global Pneumococcal Bacteria Vaccine Sales Share by Application (2016-2021)
Table 39. Global Pneumococcal Bacteria Vaccine Sales Share by Application (2022-2027)
Table 40. Global Pneumococcal Bacteria Vaccine Revenue by Application (2016-2021) & (US$ Million)
Table 41. Global Pneumococcal Bacteria Vaccine Revenue by Application (2022-2027) & (US$ Million)
Table 42. Global Pneumococcal Bacteria Vaccine Revenue Share by Application (2016-2021)
Table 43. Global Pneumococcal Bacteria Vaccine Revenue Share by Application (2022-2027)
Table 44. Pneumococcal Bacteria Vaccine Price by Application (2016-2021) & (US$/Unit)
Table 45. Global Pneumococcal Bacteria Vaccine Price Forecast by Application (2022-2027) & (US$/Unit)
Table 46. North America Pneumococcal Bacteria Vaccine Sales by Type (2016-2021) & (K Units)
Table 47. North America Pneumococcal Bacteria Vaccine Sales by Type (2022-2027) & (K Units)
Table 48. North America Pneumococcal Bacteria Vaccine Revenue by Type (2016-2021) & (US$ Million)
Table 49. North America Pneumococcal Bacteria Vaccine Revenue by Type (2022-2027) & (US$ Million)
Table 50. North America Pneumococcal Bacteria Vaccine Sales by Application (2016-2021) & (K Units)
Table 51. North America Pneumococcal Bacteria Vaccine Sales by Application (2022-2027) & (K Units)
Table 52. North America Pneumococcal Bacteria Vaccine Revenue by Application (2016-2021) & (US$ Million)
Table 53. North America Pneumococcal Bacteria Vaccine Revenue by Application (2022-2027) & (US$ Million)
Table 54. North America Pneumococcal Bacteria Vaccine Sales by Country (2016-2021) & (K Units)
Table 55. North America Pneumococcal Bacteria Vaccine Sales by Country (2022-2027) & (K Units)
Table 56. North America Pneumococcal Bacteria Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 57. North America Pneumococcal Bacteria Vaccine Revenue by Country (2022-2027) & (US$ Million)
Table 58. Europe Pneumococcal Bacteria Vaccine Sales by Type (2016-2021) & (K Units)
Table 59. Europe Pneumococcal Bacteria Vaccine Sales by Type (2022-2027) & (K Units)
Table 60. Europe Pneumococcal Bacteria Vaccine Revenue by Type (2016-2021) & (US$ Million)
Table 61. Europe Pneumococcal Bacteria Vaccine Revenue by Type (2022-2027) & (US$ Million)
Table 62. Europe Pneumococcal Bacteria Vaccine Sales by Application (2016-2021) & (K Units)
Table 63. Europe Pneumococcal Bacteria Vaccine Sales by Application (2022-2027) & (K Units)
Table 64. Europe Pneumococcal Bacteria Vaccine Revenue by Application (2016-2021) & (US$ Million)
Table 65. Europe Pneumococcal Bacteria Vaccine Revenue by Application (2022-2027) & (US$ Million)
Table 66. Europe Pneumococcal Bacteria Vaccine Sales by Country (2016-2021) & (K Units)
Table 67. Europe Pneumococcal Bacteria Vaccine Sales by Country (2022-2027) & (K Units)
Table 68. Europe Pneumococcal Bacteria Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 69. Europe Pneumococcal Bacteria Vaccine Revenue by Country (2022-2027) & (US$ Million)
Table 70. Asia Pacific Pneumococcal Bacteria Vaccine Sales by Type (2016-2021) & (K Units)
Table 71. Asia Pacific Pneumococcal Bacteria Vaccine Sales by Type (2022-2027) & (K Units)
Table 72. Asia Pacific Pneumococcal Bacteria Vaccine Revenue by Type (2016-2021) & (US$ Million)
Table 73. Asia Pacific Pneumococcal Bacteria Vaccine Revenue by Type (2022-2027) & (US$ Million)
Table 74. Asia Pacific Pneumococcal Bacteria Vaccine Sales by Application (2016-2021) & (K Units)
Table 75. Asia Pacific Pneumococcal Bacteria Vaccine Sales by Application (2022-2027) & (K Units)
Table 76. Asia Pacific Pneumococcal Bacteria Vaccine Revenue by Application (2016-2021) & (US$ Million)
Table 77. Asia Pacific Pneumococcal Bacteria Vaccine Revenue by Application (2022-2027) & (US$ Million)
Table 78. Asia Pacific Pneumococcal Bacteria Vaccine Sales by Region (2016-2021) & (K Units)
Table 79. Asia Pacific Pneumococcal Bacteria Vaccine Sales by Region (2022-2027) & (K Units)
Table 80. Asia Pacific Pneumococcal Bacteria Vaccine Revenue by Region (2016-2021) & (US$ Million)
Table 81. Asia Pacific Pneumococcal Bacteria Vaccine Revenue by Region (2022-2027) & (US$ Million)
Table 82. Latin America Pneumococcal Bacteria Vaccine Sales by Type (2016-2021) & (K Units)
Table 83. Latin America Pneumococcal Bacteria Vaccine Sales by Type (2022-2027) & (K Units)
Table 84. Latin America Pneumococcal Bacteria Vaccine Revenue by Type (2016-2021) & (US$ Million)
Table 85. Latin America Pneumococcal Bacteria Vaccine Revenue by Type (2022-2027) & (US$ Million)
Table 86. Latin America Pneumococcal Bacteria Vaccine Sales by Application (2016-2021) & (K Units)
Table 87. Latin America Pneumococcal Bacteria Vaccine Sales by Application (2022-2027) & (K Units)
Table 88. Latin America Pneumococcal Bacteria Vaccine Revenue by Application (2016-2021) & (US$ Million)
Table 89. Latin America Pneumococcal Bacteria Vaccine Revenue by Application (2022-2027) & (US$ Million)
Table 90. Latin America Pneumococcal Bacteria Vaccine Sales by Country (2016-2021) & (K Units)
Table 91. Latin America Pneumococcal Bacteria Vaccine Sales by Country (2022-2027) & (K Units)
Table 92. Latin America Pneumococcal Bacteria Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 93. Latin America Pneumococcal Bacteria Vaccine Revenue by Country (2022-2027) & (US$ Million)
Table 94. Middle East and Africa Pneumococcal Bacteria Vaccine Sales by Type (2016-2021) & (K Units)
Table 95. Middle East and Africa Pneumococcal Bacteria Vaccine Sales by Type (2022-2027) & (K Units)
Table 96. Middle East and Africa Pneumococcal Bacteria Vaccine Revenue by Type (2016-2021) & (US$ Million)
Table 97. Middle East and Africa Pneumococcal Bacteria Vaccine Revenue by Type (2022-2027) & (US$ Million)
Table 98. Middle East and Africa Pneumococcal Bacteria Vaccine Sales by Application (2016-2021) & (K Units)
Table 99. Middle East and Africa Pneumococcal Bacteria Vaccine Sales by Application (2022-2027) & (K Units)
Table 100. Middle East and Africa Pneumococcal Bacteria Vaccine Revenue by Application (2016-2021) & (US$ Million)
Table 101. Middle East and Africa Pneumococcal Bacteria Vaccine Revenue by Application (2022-2027) & (US$ Million)
Table 102. Middle East and Africa Pneumococcal Bacteria Vaccine Sales by Country (2016-2021) & (K Units)
Table 103. Middle East and Africa Pneumococcal Bacteria Vaccine Sales by Country (2022-2027) & (K Units)
Table 104. Middle East and Africa Pneumococcal Bacteria Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 105. Middle East and Africa Pneumococcal Bacteria Vaccine Revenue by Country (2022-2027) & (US$ Million)
Table 106. Merck Corporation Information
Table 107. Merck Description and Major Businesses
Table 108. Merck Pneumococcal Bacteria Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 109. Merck Pneumococcal Bacteria Vaccine Product
Table 110. Merck Recent Developments
Table 111. Sanofi Corporation Information
Table 112. Sanofi Description and Major Businesses
Table 113. Sanofi Pneumococcal Bacteria Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 114. Sanofi Pneumococcal Bacteria Vaccine Product
Table 115. Sanofi Recent Developments
Table 116. Sinopharm Corporation Information
Table 117. Sinopharm Description and Major Businesses
Table 118. Sinopharm Pneumococcal Bacteria Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 119. Sinopharm Pneumococcal Bacteria Vaccine Product
Table 120. Sinopharm Recent Developments
Table 121. Pfizer Corporation Information
Table 122. Pfizer Description and Major Businesses
Table 123. Pfizer Pneumococcal Bacteria Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 124. Pfizer Pneumococcal Bacteria Vaccine Product
Table 125. Pfizer Recent Developments
Table 126. Walvax Corporation Information
Table 127. Walvax Description and Major Businesses
Table 128. Walvax Pneumococcal Bacteria Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 129. Walvax Pneumococcal Bacteria Vaccine Product
Table 130. Walvax Recent Developments
Table 131. GSK Corporation Information
Table 132. GSK Description and Major Businesses
Table 133. GSK Pneumococcal Bacteria Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 134. GSK Pneumococcal Bacteria Vaccine Product
Table 135. GSK Recent Developments
Table 136. Key Raw Materials Lists
Table 137. Raw Materials Key Suppliers Lists
Table 138. Pneumococcal Bacteria Vaccine Distributors List
Table 139. Pneumococcal Bacteria Vaccine Customers List
Table 140. Pneumococcal Bacteria Vaccine Market Trends
Table 141. Pneumococcal Bacteria Vaccine Market Drivers
Table 142. Pneumococcal Bacteria Vaccine Market Challenges
Table 143. Pneumococcal Bacteria Vaccine Market Restraints
Table 144. Research Programs/Design for This Report
Table 145. Key Data Information from Secondary Sources
Table 146. Key Data Information from Primary Sources
List of Figures
Figure 1. Pneumococcal Bacteria Vaccine Product Picture
Figure 2. Global Pneumococcal Bacteria Vaccine Market Share by Type in 2020 & 2027
Figure 3. PPSV 23 Product Picture
Figure 4. PCV 13 Product Picture
Figure 5. PCV 10 Product Picture
Figure 6. Global Pneumococcal Bacteria Vaccine Market Share by Application in 2020 & 2027
Figure 7. Infant
Figure 8. Children
Figure 9. Adult
Figure 10. Pneumococcal Bacteria Vaccine Report Years Considered
Figure 11. Global Pneumococcal Bacteria Vaccine Sales 2016-2027 (K Units)
Figure 12. Global Pneumococcal Bacteria Vaccine Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Pneumococcal Bacteria Vaccine Revenue 2016-2027 (US$ Million)
Figure 14. Global Pneumococcal Bacteria Vaccine Revenue Market Share by Region in Percentage: 2020 Versus 2027
Figure 15. Global Pneumococcal Bacteria Vaccine Sales Market Share by Region (2016-2021)
Figure 16. Global Pneumococcal Bacteria Vaccine Sales Market Share by Region (2022-2027)
Figure 17. North America Pneumococcal Bacteria Vaccine Sales YoY (2016-2027) & (K Units)
Figure 18. North America Pneumococcal Bacteria Vaccine Revenue YoY (2016-2027) & (US$ Million)
Figure 19. Europe Pneumococcal Bacteria Vaccine Sales YoY (2016-2027) & (K Units)
Figure 20. Europe Pneumococcal Bacteria Vaccine Revenue YoY (2016-2027) & (US$ Million)
Figure 21. Asia-Pacific Pneumococcal Bacteria Vaccine Sales YoY (2016-2027) & (K Units)
Figure 22. Asia-Pacific Pneumococcal Bacteria Vaccine Revenue YoY (2016-2027) & (US$ Million)
Figure 23. Latin America Pneumococcal Bacteria Vaccine Sales YoY (2016-2027) & (K Units)
Figure 24. Latin America Pneumococcal Bacteria Vaccine Revenue YoY (2016-2027) & (US$ Million)
Figure 25. Middle East & Africa Pneumococcal Bacteria Vaccine Sales YoY (2016-2027) & (K Units)
Figure 26. Middle East & Africa Pneumococcal Bacteria Vaccine Revenue YoY (2016-2027) & (US$ Million)
Figure 27. The Top 10 and Top 5 Players Market Share by Pneumococcal Bacteria Vaccine Sales in 2020
Figure 28. The Top 10 and Top 5 Players Market Share by Pneumococcal Bacteria Vaccine Revenue in 2020
Figure 29. Pneumococcal Bacteria Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020
Figure 30. Global Pneumococcal Bacteria Vaccine Sales Market Share by Type (2016-2027)
Figure 31. Global Pneumococcal Bacteria Vaccine Revenue Market Share by Type (2016-2027)
Figure 32. Global Pneumococcal Bacteria Vaccine Sales Market Share by Application (2016-2027)
Figure 33. Global Pneumococcal Bacteria Vaccine Revenue Market Share by Application (2016-2027)
Figure 34. North America Pneumococcal Bacteria Vaccine Sales Market Share by Type (2016-2027)
Figure 35. North America Pneumococcal Bacteria Vaccine Revenue Market Share by Type (2016-2027)
Figure 36. North America Pneumococcal Bacteria Vaccine Sales Market Share by Application (2016-2027)
Figure 37. North America Pneumococcal Bacteria Vaccine Revenue Market Share by Application (2016-2027)
Figure 38. North America Pneumococcal Bacteria Vaccine Sales Share by Country (2016-2027)
Figure 39. North America Pneumococcal Bacteria Vaccine Revenue Share by Country (2016-2027)
Figure 40. United States Pneumococcal Bacteria Vaccine Revenue (2016-2027) & (US$ Million)
Figure 41. Canada Pneumococcal Bacteria Vaccine Revenue (2016-2027) & (US$ Million)
Figure 42. Europe Pneumococcal Bacteria Vaccine Sales Market Share by Type (2016-2027)
Figure 43. Europe Pneumococcal Bacteria Vaccine Revenue Market Share by Type (2016-2027)
Figure 44. Europe Pneumococcal Bacteria Vaccine Sales Market Share by Application (2016-2027)
Figure 45. Europe Pneumococcal Bacteria Vaccine Revenue Market Share by Application (2016-2027)
Figure 46. Europe Pneumococcal Bacteria Vaccine Sales Share by Country (2016-2027)
Figure 47. Europe Pneumococcal Bacteria Vaccine Revenue Share by Country (2016-2027)
Figure 48. Germany Pneumococcal Bacteria Vaccine Revenue (2016-2027) & (US$ Million)
Figure 49. France Pneumococcal Bacteria Vaccine Revenue (2016-2027) & (US$ Million)
Figure 50. U.K. Pneumococcal Bacteria Vaccine Revenue (2016-2027) & (US$ Million)
Figure 51. Italy Pneumococcal Bacteria Vaccine Revenue (2016-2027) & (US$ Million)
Figure 52. Russia Pneumococcal Bacteria Vaccine Revenue (2016-2027) & (US$ Million)
Figure 53. Asia Pacific Pneumococcal Bacteria Vaccine Sales Market Share by Type (2016-2027)
Figure 54. Asia Pacific Pneumococcal Bacteria Vaccine Revenue Market Share by Type (2016-2027)
Figure 55. Asia Pacific Pneumococcal Bacteria Vaccine Sales Market Share by Application (2016-2027)
Figure 56. Asia Pacific Pneumococcal Bacteria Vaccine Revenue Market Share by Application (2016-2027)
Figure 57. Asia Pacific Pneumococcal Bacteria Vaccine Sales Share by Region (2016-2027)
Figure 58. Asia Pacific Pneumococcal Bacteria Vaccine Revenue Share by Region (2016-2027)
Figure 59. China Pneumococcal Bacteria Vaccine Revenue (2016-2027) & (US$ Million)
Figure 60. Japan Pneumococcal Bacteria Vaccine Revenue (2016-2027) & (US$ Million)
Figure 61. South Korea Pneumococcal Bacteria Vaccine Revenue (2016-2027) & (US$ Million)
Figure 62. India Pneumococcal Bacteria Vaccine Revenue (2016-2027) & (US$ Million)
Figure 63. Australia Pneumococcal Bacteria Vaccine Revenue (2016-2027) & (US$ Million)
Figure 64. China Taiwan Pneumococcal Bacteria Vaccine Revenue (2016-2027) & (US$ Million)
Figure 65. Indonesia Pneumococcal Bacteria Vaccine Revenue (2016-2027) & (US$ Million)
Figure 66. Thailand Pneumococcal Bacteria Vaccine Revenue (2016-2027) & (US$ Million)
Figure 67. Malaysia Pneumococcal Bacteria Vaccine Revenue (2016-2027) & (US$ Million)
Figure 68. Latin America Pneumococcal Bacteria Vaccine Sales Market Share by Type (2016-2027)
Figure 69. Latin America Pneumococcal Bacteria Vaccine Revenue Market Share by Type (2016-2027)
Figure 70. Latin America Pneumococcal Bacteria Vaccine Sales Market Share by Application (2016-2027)
Figure 71. Latin America Pneumococcal Bacteria Vaccine Revenue Market Share by Application (2016-2027)
Figure 72. Latin America Pneumococcal Bacteria Vaccine Sales Share by Country (2016-2027)
Figure 73. Latin America Pneumococcal Bacteria Vaccine Revenue Share by Country (2016-2027)
Figure 74. Mexico Pneumococcal Bacteria Vaccine Revenue (2016-2027) & (US$ Million)
Figure 75. Brazil Pneumococcal Bacteria Vaccine Revenue (2016-2027) & (US$ Million)
Figure 76. Argentina Pneumococcal Bacteria Vaccine Revenue (2016-2027) & (US$ Million)
Figure 77. Middle East and Africa Pneumococcal Bacteria Vaccine Sales Market Share by Type (2016-2027)
Figure 78. Middle East and Africa Pneumococcal Bacteria Vaccine Revenue Market Share by Type (2016-2027)
Figure 79. Middle East and Africa Pneumococcal Bacteria Vaccine Sales Market Share by Application (2016-2027)
Figure 80. Middle East and Africa Pneumococcal Bacteria Vaccine Revenue Market Share by Application (2016-2027)
Figure 81. Middle East and Africa Pneumococcal Bacteria Vaccine Sales Share by Country (2016-2027)
Figure 82. Middle East and Africa Pneumococcal Bacteria Vaccine Revenue Share by Country (2016-2027)
Figure 83. Turkey Pneumococcal Bacteria Vaccine Revenue (2016-2027) & (US$ Million)
Figure 84. Saudi Arabia Pneumococcal Bacteria Vaccine Revenue (2016-2027) & (US$ Million)
Figure 85. UAE Pneumococcal Bacteria Vaccine Revenue (2016-2027) & (US$ Million)
Figure 86. Pneumococcal Bacteria Vaccine Value Chain
Figure 87. Pneumococcal Bacteria Vaccine Production Process
Figure 88. Channels of Distribution
Figure 89. Distributors Profiles
Figure 90. Bottom-up and Top-down Approaches for This Report
Figure 91. Data Triangulation
Figure 92. Key Executives Interviewed

---